| 6/26/2024 | DD | NanoString Technologies’ Chapter 11 plan effective as of June 26
|
| 6/20/2024 | DD | NanoString Technologies receives confirmation of Chapter 11 plan
|
| 6/14/2024 | DD | NanoString’s Chapter 11 plan accepted by unsecured noteholder class
|
| 6/7/2024 | DD | NanoString gets approval of settlement with 2026 secured noteholders
|
| 6/4/2024 | DD | NanoString asks for 60-day extension of exclusive plan periods
|
| 5/23/2024 | DD | NanoString’s disclosure statement approved; plan hearing June 18
|
| 5/22/2024 | DD | NanoString reports $58.69 million net loss for April
|
| 5/15/2024 | DD | NanoString’s disclosure statement draws objection from noteholders
|
| 4/23/2024 | DD | NanoString reports $5.31 million net loss for March
|
| 4/19/2024 | DD | NanoString gets nod for $392.6 million asset sale to Bruker
|
| 4/17/2024 | DD | NanoString eyes $392.6 million asset sale to winning bidder Bruker
|
| 4/16/2024 | DD | NanoString Technologies files Chapter 11 plan, disclosure statement
|
| 4/1/2024 | DD | NanoString receives court approval of bid procedures for assets
|
| 3/26/2024 | DD | NanoString: U.S. trustee objects to stalking horse bid protections
|
| 3/22/2024 | DD | NanoString reports $16.47 million net loss for February
|
| 3/20/2024 | DD | NanoString gets final approval of amended $47.5 million DIP financing
|
| 3/11/2024 | DD | NanoString files bid procedures, gets $220 million stalking horse bid
|
| 2/29/2024 | DD | NanoString: Unsecured creditors committee objects to DIP financing
|
| 2/16/2024 | DD | NanoString’s official committee of unsecured creditors appointed
|
| 2/9/2024 | BKCVDDEMHY | Prospect News reports three new defaults for Feb. 1-Feb. 7
|
| 2/7/2024 | DD | NanoString gets interim OK of $142.5 million DIP financing package
|
| 2/6/2024 | DD | NanoString details terms of $142.5 million DIP financing package
|
| 2/5/2024 | DD | NanoString files bankruptcy in wake of 10x Genomics litigation
|
| 3/6/2020 | CV | Market Commentary: Cypress drops outright, expands dollar-neutral; BridgeBio weakens; NanoString gains
|
| 3/5/2020 | CV | Market Commentary: Convertibles primary prices $1.2 billion in four deals; BridgeBio, NanoString soar
|
| 3/5/2020 | CV | Market Commentary: Morning Commentary: Convertibles primary market prices $1.2 billion in four deals
|
| 3/5/2020 | CV | New Issue: NanoString prices upsized $200 million 2.625% convertible notes due 2025, up 40%
|
| 3/4/2020 | CV | Market Commentary: Infinera, Enphase, NanoString Technologies, BridgeBio convertible note offerings eyed
|
| 3/4/2020 | BK | NanoString to prepay term loan with proceeds from convertible notes
|
| 3/4/2020 | CV | Market Commentary: Morning Commentary: Infinera, Enphase, NanoString Technologies, BridgeBio notes on tap
|
| 3/4/2020 | CV | NanoString Technologies talks $175 million five-year convertibles at 2.375%-2.875%, up 37.5%-42.5%
|
| 10/15/2018 | BKPV | New Issue: Nanostring secures $100 million via six-year 10% term loan facility
|
| 5/12/2015 | PP | NanoString Technologies inks $40 million at-the-market sales agreement
|
| 4/3/2014 | PV | NanoString secures up to $45 million of funding from Capital Royalty
|
| 1/23/2014 | PP | NanoString prices $55 million public sale of common stock at $18.50
|
| 1/21/2014 | PP | Nanostring intends to price $55 million public sale of common stock
|
| 1/13/2014 | PP | Nanostring plans $55 million follow-on offering of common stock
|
| 6/26/2013 | PP | NanoString prices $54 million initial public stock offering at $10.00
|
| 5/20/2013 | PP | Nanostring Technologies aims to price initial public offering of stock
|
